Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | KRW 37.13T | 181.4x | -2.58 | KRW 180,100 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.8% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 3.82T | -1,131.6x | -13.44 | KRW 104,700 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.82T | KRW 22,850 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.8T | -80.9x | 12.89 | KRW 87,100 | -7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.41T | -35.9x | 4.98 | KRW 78,700 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.39T | -27x | 0.06 | KRW 28,800 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 1.06T | 36.2x | 0.03 | KRW 22,900 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 488.03B | -37.1x | -12.15 | KRW 20,350 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 487.56B | -19.3x | 0.03 | KRW 18,890 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 425.78B | -16x | 0.82 | KRW 24,700 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 405.92B | -14.1x | 1.75 | KRW 2,955 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 337.52B | KRW 15,400 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 334.58B | -6.5x | 0.03 | KRW 39,200 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 322.23B | -32.2x | 0.03 | KRW 9,450 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corestem | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 296.95B | -6.2x | 0.04 | KRW 12,190 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 267.87B | -26.9x | -29.12 | KRW 11,650 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellivery | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 248.38B | -0.44 | KRW 6,680 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 243.32B | -4.4x | -0.08 | KRW 5,350 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 233.76B | -0.45 | KRW 2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 187.17B | -3.7x | 0.09 | KRW 7,410 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 183.63B | KRW 3,350 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 175.6B | -36.4x | -0.74 | KRW 5,310 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 172.74B | 31.1x | 0.08 | KRW 2,020 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 168.28B | -7x | 0.17 | KRW 6,260 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 166.88B | KRW 15,320 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 166.37B | -33x | 0.14 | KRW 1,976 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | KRW 162.05B | -2.3x | 0.06 | KRW 2,030 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 156.67B | -8x | -3.06 | KRW 15,700 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 150.27B | -5.9x | -0.16 | KRW 4,475 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | KRW 145.44B | -3x | -0.19 | KRW 2,885 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |